Clinical Trial: An Observational Study on the Safety and Efficacy of Henggliflozin in Chinese Patients With Type 2 Diabetes

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06959030) titled 'An Observational Study on the Safety and Efficacy of Henggliflozin in Chinese Patients With Type 2 Diabetes' on April 16.

Brief Summary: An Observational Study on the Safety and Efficacy of Henggliflozin in Chinese Patients with Type 2 Diabetes Primary Research Objective

* To evaluate the safety of Henggliflozin in Chinese patients with type 2 diabetes mellitus (T2DM) in real world.

Exploratory Research Objectives

* 1. Improvement in metabolic parameters: To assess changes in metabolic indicators, including glycated hemoglobin (HbA1c), fasting plasma glucose (FPG), 2-hour postprandial plasma glucose (PPG), blood pressure, and body ...